The Rate of Immune Escape Vanishes When Multiple Immune Responses Control an HIV Infection
暂无分享,去创建一个
Rob J. de Boer | R. D. de Boer | Hanneke W. M. van Deutekom | Gilles Wijnker | H. W. van Deutekom | G. Wijnker
[1] Alan S. Perelson,et al. CD8+ Lymphocytes Control Viral Replication in SIVmac239-Infected Rhesus Macaques without Decreasing the Lifespan of Productively Infected Cells , 2010, PLoS pathogens.
[2] Masami Hasegawa,et al. Estimation of effective population size of HIV-1 within a host: a pseudomaximum-likelihood approach. , 2002, Genetics.
[3] J. Lundeberg,et al. Dynamics of HIV-1 Quasispecies during Antiviral Treatment Dissected Using Ultra-Deep Pyrosequencing , 2010, PloS one.
[4] Rob J. de Boer,et al. Understanding the failure of CD8 T-cell vaccination against simian/human immunodeficiency virus , 2007 .
[5] Martin A. Nowak,et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS , 1997, Nature Medicine.
[6] Todd M. Allen,et al. Limited Sequence Evolution within Persistently Targeted CD8 Epitopes in Chronic Human Immunodeficiency Virus Type 1 Infection , 2005, Journal of Virology.
[7] Rob J. De Boer. Which of Our Modeling Predictions Are Robust? , 2012, PLoS Comput. Biol..
[8] Yi Liu,et al. Selection dramatically reduces effective population size in HIV-1 infection , 2007, BMC Evolutionary Biology.
[9] Christian L. Althaus,et al. Implications of CTL-Mediated Killing of HIV-Infected Cells during the Non-Productive Stage of Infection , 2011, PloS one.
[10] Philip J. R. Goulder,et al. Compensatory Mutation Partially Restores Fitness and Delays Reversion of Escape Mutation within the Immunodominant HLA-B*5703-Restricted Gag Epitope in Chronic Human Immunodeficiency Virus Type 1 Infection , 2007, Journal of Virology.
[11] Rob J. De Boer,et al. Degenerate T-cell Recognition of Peptides on MHC Molecules Creates Large Holes in the T-cell Repertoire , 2012, PLoS Comput. Biol..
[12] L. M. Mansky,et al. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase , 1995, Journal of virology.
[13] Todd M. Allen,et al. Escape and Compensation from Early HLA-B57-Mediated Cytotoxic T-Lymphocyte Pressure on Human Immunodeficiency Virus Type 1 Gag Alter Capsid Interactions with Cyclophilin A , 2007, Journal of Virology.
[14] Todd M. Allen,et al. Persistent Recognition of Autologous Virus by High-Avidity CD8 T Cells in Chronic, Progressive Human Immunodeficiency Virus Type 1 Infection , 2004, Journal of Virology.
[15] S. Pillai,et al. In Vivo CD8+ T-Cell Suppression of SIV Viremia Is Not Mediated by CTL Clearance of Productively Infected Cells , 2010, PLoS pathogens.
[16] E. Rosenberg,et al. Impaired Replication Capacity of Acute/Early Viruses in Persons Who Become HIV Controllers , 2010, Journal of Virology.
[17] P. Kahn. Susceptibility Genes: Pointing a Way to Prevention? , 1996, Science.
[18] Rustom Antia,et al. Roles of Target Cells and Virus-Specific Cellular Immunity in Primary Simian Immunodeficiency Virus Infection , 2004, Journal of Virology.
[19] L. Segel,et al. Extending the quasi-steady state approximation by changing variables. , 1996, Bulletin of mathematical biology.
[20] E. Rosenberg,et al. Immune control of HIV-1 after early treatment of acute infection , 2000, Nature.
[21] David Heckerman,et al. Progression to AIDS in South Africa Is Associated with both Reverting and Compensatory Viral Mutations , 2011, PloS one.
[22] Angela R. McLean,et al. Modelling the Evolution and Spread of HIV Immune Escape Mutants , 2010, PLoS pathogens.
[23] Huldrych F. Günthard,et al. Whole Genome Deep Sequencing of HIV-1 Reveals the Impact of Early Minor Variants Upon Immune Recognition During Acute Infection , 2012, PLoS pathogens.
[24] R. D. de Boer,et al. Understanding the Failure of CD8+ T-Cell Vaccination against Simian/Human Immunodeficiency Virus , 2007, Journal of Virology.
[25] A S Perelson,et al. Towards a general function describing T cell proliferation. , 1995, Journal of theoretical biology.
[26] Martin A. Nowak,et al. Antigenic oscillations and shifting immunodominance in HIV-1 infections , 1995, Nature.
[27] H. Schuitemaker,et al. No Treatment versus 24 or 60 Weeks of Antiretroviral Treatment during Primary HIV Infection: The Randomized Primo-SHM Trial , 2012, PLoS medicine.
[28] Mario Roederer,et al. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection , 2005, Nature.
[29] Austin Hughes,et al. Ultradeep Pyrosequencing Detects Complex Patterns of CD8+ T-Lymphocyte Escape in Simian Immunodeficiency Virus-Infected Macaques , 2009, Journal of Virology.
[30] L M Wahl,et al. Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[31] Roland R. Regoes,et al. Estimating the Effectiveness of Simian Immunodeficiency Virus-Specific CD8+ T Cells from the Dynamics of Viral Immune Escape , 2007, Journal of Virology.
[32] C. Gray,et al. Virological and Immunological Factors Associated with HIV-1 Differential Disease Progression in HLA-B*58:01-Positive Individuals , 2011, Journal of Virology.
[33] Alan S. Perelson,et al. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection , 2009, The Journal of experimental medicine.
[34] Christian L. Althaus,et al. Dynamics of Immune Escape during HIV/SIV Infection , 2008, PLoS Comput. Biol..
[35] D. Heckerman,et al. Co-Operative Additive Effects between HLA Alleles in Control of HIV-1 , 2012, PloS one.
[36] Eric Barklis,et al. Second-Site Compensatory Mutations of HIV-1 Capsid Mutations , 2011, Journal of Virology.
[37] Douglas D. Richman,et al. Viral Dynamics of Acute HIV-1 Infection , 1999, The Journal of experimental medicine.
[38] Christian Brander,et al. Selective Escape from CD8+ T-Cell Responses Represents a Major Driving Force of Human Immunodeficiency Virus Type 1 (HIV-1) Sequence Diversity and Reveals Constraints on HIV-1 Evolution , 2005, Journal of Virology.
[39] Alan S Perelson,et al. Estimates of Intracellular Delay and Average Drug Efficacy from Viral Load Data of HIV-Infected Individuals under Antiretroviral Therapy , 2004, Antiviral therapy.
[40] Brigitte Autran,et al. Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study , 2013, PLoS pathogens.
[41] A. Perelson,et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.
[42] Becca Asquith,et al. Inefficient Cytotoxic T Lymphocyte–Mediated Killing of HIV-1–Infected Cells In Vivo , 2006, PLoS biology.
[43] Winston A Hide,et al. Transmission of HIV-1 CTL Escape Variants Provides HLA-Mismatched Recipients with a Survival Advantage , 2008, PLoS pathogens.
[44] Christian Brander,et al. Virological, Immune and Host genetics Markers in the Control of HIV Infection , 2009, Disease markers.
[45] Andrew N. Phillips,et al. Reduction of HIV Concentration During Acute Infection: Independence from a Specific Immune Response , 1996, Science.
[46] Alan S. Perelson,et al. Current Estimates for HIV-1 Production Imply Rapid Viral Clearance in Lymphoid Tissues , 2010, PLoS Comput. Biol..
[47] Feng Gao,et al. Vertical T cell immunodominance and epitope entropy determine HIV-1 escape. , 2012, The Journal of clinical investigation.
[48] M. Prins,et al. Transient lowering of the viral set point after temporary antiretroviral therapy of primary HIV type 1 infection. , 2010, AIDS research and human retroviruses.
[49] Sebastian Bonhoeffer,et al. Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis , 1999, The Lancet.
[50] Yi Liu,et al. Dynamics of Viral Evolution and CTL Responses in HIV-1 Infection , 2011, PloS one.
[51] N. Dixit,et al. Taking Multiple Infections of Cells and Recombination into Account Leads to Small Within-Host Effective-Population-Size Estimates of HIV-1 , 2011, PloS one.
[52] Becca Asquith,et al. Quantifying the Impact of Human Immunodeficiency Virus-1 Escape From Cytotoxic T-Lymphocytes , 2010, PLoS Comput. Biol..
[53] Alan S. Perelson,et al. Transmission of Single HIV-1 Genomes and Dynamics of Early Immune Escape Revealed by Ultra-Deep Sequencing , 2010, PloS one.
[54] B. Walker,et al. Fitness Cost of Escape Mutations in p24 Gag in Association with Control of Human Immunodeficiency Virus Type 1 , 2006, Journal of Virology.
[55] Alan S. Perelson,et al. Fitness Costs and Diversity of the Cytotoxic T Lymphocyte (CTL) Response Determine the Rate of CTL Escape during Acute and Chronic Phases of HIV Infection , 2011, Journal of Virology.
[56] A. Perelson,et al. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.
[57] Alan S. Perelson,et al. Kinetics of Virus-Specific CD8+ T Cells and the Control of Human Immunodeficiency Virus Infection , 2004, Journal of Virology.
[58] D. Montefiori,et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. , 1999, Science.